Classically, the amino acid neurotransmitters glutamate, GABA, and glycine mediate rapid, spatially localized, pointto-point neurotransmission. In contrast, the action of the amine transmitters noradrenaline, dopamine, and serotonin can be more widespread, slower, and modulatory, resulting from the amine transmitter diffusing through the extracellular space and acting on a spatially broader pool of cells (Fuxe et al., 2015; Moss and Bolam, 2008) . In mammals, noradrenaline release generates arousal, attention, wakefulness, and fight or flight responses, while dopamine modulates motor function and signals some aspects of reward. Similarly, lower down the evolutionary tree in invertebrates, the adrenaline/noradrenaline analogs octopamine and tyramine promote arousal and wakefulness, mediate fight or flight responses, and regulate metabolism, while dopamine modulates behaviors from locomotion and sleep to courtship and learning. Amine transmitters have been thought to produce these effects by acting directly on neurons to regulate their excitability and synaptic strength. Surprisingly, however, recent experiments have suggested that a major contributor to the CNS actions of octopamine/tyramine (Oct/Tyr) in flies and of noradrenaline in mammals is a rise of [Ca 2+ ] i in astrocytes, which leads to a release of factors that modulate neuronal function and behavior.
Neurotransmitter release from neurons is one cause of astrocyte [Ca 2+ ] i transients (reviewed by Bazargani and Attwell, 2016) . In line with this, a new study found that, in Drosophila larvae, one-half to three-quarters of the [Ca 2+ ] i transients in ventral nerve cord astrocyte cell bodies were driven by Oct/Tyr signaling from neurons that receive olfactory input (Ma et al., 2016 ] i transient rate (with no change in the firing of Oct/Tyr neurons). Knockdown of Wtrw, or of the Oct/Tyr receptor, in astrocytes also inhibited larval chemotaxis to an olfactory stimulus and startle-induced escape responses (Ma et al., 2016) . This behavioral inhibition resulted from the block of a pathway ( Figure 1A) ] i responses evoked are larger than with either alone (Paukert et al., 2014) . It is possible that this synergy occurs at the level of the locus coeruleus, with the combination of movement and visual stimuli evoking more firing of the locus coeruleus neurons that release noradrenaline in visual cortex. Alternatively, this synergy might be generated locally in cortical astrocytes: when noradrenaline is being released from locus coeruleus axons, astrocyte [Ca 2+ ] i rises evoked by local neuronal activity may be potentiated, along with the downstream effects on neuronal function that they produce (see below). The spatially extensive nature of the locus coeruleus axons, together with the large number of synapses that each astrocyte is associated with, thus confers a mechanism by which information processing throughout a large region of the brain can be modulated-a phenomenon that could underlie context-dependent gating of attention and arousal by noradrenaline.
Examination of how [Ca 2+ ] i is elevated in fly and rodent astrocytes reveals similarities between the signaling mechanisms in the different species but also raises questions that it will be important to resolve in order to fully understand the function of amine transmitter signaling via astrocytes. In mammalian astrocytes, [Ca 2+ ] i can be raised by neurotransmitters, such as noradrenaline or glutamate, acting on G-protein-coupled receptors that activate phospholipase C (PLC) to generate IP 3 and release Ca 2+ from internal stores ( Figure 1B) . Alternatively, Ca
2+
can enter across the cell membrane through ion channels, such as ATP-gated P2X 1 receptors (Mishra et al., 2016) or spontaneously active TRPA1 channels, in astrocyte processes (Shigetomi et al., 2011) . TRPA1-mediated Ca 2+ entry into mammalian astrocytes suggests a similarity with the mechanism by which the TRP channel Wtrw contributes to the [Ca 2+ ] i transients in fly astrocytes. Indeed, a BLAST homology search on Wtrw indicates that its closest related rodent protein is TRPA1.
This might seem to indicate a satisfying preservation across species-by evolution-of an important signaling mechanism. However, there is controversy over the dependence of the resulting TRPmediated [Ca 2+ ] i transients on neuronal activity. The Drosophila larva work indicated that Wtrw is activated by amine neurotransmitters acting on the Oct/Tyr receptor on astrocytes (Ma et al., 2016) , which couples to G i and G q proteins to inhibit adenylate cyclase and activate PLC (Robb et al., 1994 oxygen species that are released in association with mPTP opening (Angelova et al., 2015; Zorov et al., 2014) . Since neuronal activity localizes mitochondria at positions in astrocyte processes that are near synapses (Stephen et al., 2015) , this mechanism will tend to produce ] i transients in these three studies might reflect the different ages of animal studied, difficulty in dissolving the TRPA1 blocker used (HC030031, which is rather insoluble), or some yet-to-be-determined difference in the state of the preparations.
The ] i transients even when the main astrocyte IP3 receptor (IP3R 2 ) mediating release from internal stores is knocked out (Agarwal et al., 2017) . This increase in [Ca 2+ ] i transients could reflect increased mPTP opening, produced when noradrenaline increases the rate of oxidative phosphorylation by stimulating breakdown of astrocyte glycogen, providing a mechanism coupling metabolism to astrocyte signaling. A key issue, for understanding how amine neurotransmitters might gate arousal, as outlined above, is how local release of fast transmitters, such as glutamate, and more global release of noradrenaline (and perhaps other amine transmitters) might synergistically evoke a [Ca 2+ ] i signal in astrocytes that is larger than for either stimulus alone (Paukert et al., 2014 (Berridge, 2016) , a rise in [Ca 2+ ] i produced by any of the mechanisms above could synergize supralinearly with Ca 2+ released from internal stores by noradrenaline to generate more Ca 2+ release from the stores than would occur if only noradrenaline release or only local release of fast neurotransmitters occurred ( Figure 1B) . Alternatively, a rise in cyclic AMP level produced by local neuronal activity can potentiate IP3 receptormediated Ca 2+ release (Taylor, 2016) and ] i changes altering the surface expression of neurotransmitter transporters (which regulate transmitter action in flies as in mammals: MacNamee et al., 2016), or perhaps of surface membrane enzymes that hydrolyze ATP, thus altering the level of neurotransmitters or adenosine reaching the surrounding neurons (Shigetomi et al., 2011; discussed in Bazargani and Attwell, 2016) . Additionally, the reported increase of astrocyte volume evoked during arousal by noradrenaline activating b receptors (Sherpa et al., 2016) , which may contribute to the decrease in extracellular volume seen during wake periods , may alter the concentration of neurotransmitters in the extracellular space. Establishing the mechanism of this swelling, which could reflect an increased ion influx into astrocytes or a decrease of Na/K pump activity, is an important issue for the future.
We have focused here on the actions of noradrenaline on astrocytes, but dopamine and 5-HT also evoke astrocyte [Ca 2+ ] i rises that may similarly alter neuronal function. These rises can occur by the transmitters acting on receptors or, in a non-receptor manner, by intracellular oxidation and generation of reactive oxygen species that activate PLC to release Ca 2+ from internal stores (Vaarmann et al., 2010; Jennings et al., 2017; Schipke et al., 2011) . Intriguingly, in the mammalian brain, astrocytes have also been suggested to regulate the release of noradrenaline from locus coeruleus neurons using lactate as a gliotransmitter (Tang et al., 2014) . To sum up, wide-ranging aminergic axons may be able to gate arousal and other behavioral changes by raising astrocyte [Ca 2+ ] i levels. A key question raised by this work is the relative importance of amine signaling that is mediated by astrocytes as opposed to mediated by direct effects of amine transmitters on neurons. The demonstration of amineregulated behavior produced by astrocytes raises the possibility of new pharmacological targets for therapy once the underlying mechanisms are completely understood.
